Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-31

Clinical Trial Update: Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P [NA]

View source ↗

Summary

Clinical trial update examining nicotine pharmacokinetics, pharmacodynamics, safety, and tolerability of P3P; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • P3P (P3P)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Pharmacokinetics | NA | Status: COMPLETED | Results posted: 2020-01-31